The 60 Day Challenge enrollment has ended but you can contribute to training the system by using Face2Gene. Need a Face2Gene account? Register Here.


Help the Genetics Community

Face2Gene issued a call to all genetics providers to give back to the genetics community. Participants use Face2Gene to help evaluate every patient for 60 days to help improve facial analysis in the rare disease setting.

All participants receive 60 days free access to London Medical Databases (LMD) through Face2Gene LIBRARY.


Bonus: Genetic Testing Vouchers & LMD Access

A number of labs have partnered with FDNA to thank users for their help. Genetic testing (exome) vouchers will be awarded to the individuals and teams with the highest level of participation after 60 days. The vouchers can be applied to undiagnosed cases within the secure Face2Gene Unknown Forum. Participants in each pledge category also will receive additional London Medical Databases (LMD) access through Face2Gene LIBRARY. See prize details in the pledge section below.


Pledge/Prize Categories

Genetic testing voucher prizes are determined based on the number of cases participants pledge to evaluate over 60 days


  • 40 Cases (1 case per weekday average) Prize: 1 exome AND 3 more months individual LMD subscription
  • 80 Cases (2 cases per weekday average) Prize: 2 exomes AND 6 more months individual LMD subscription
  • 120 Cases (3 cases per weekday average) Prize: 1 trio or 3 exomes AND 12 more months individual LMD subscription
  • 120 Cases (3 cases per weekday average) Prize: 1 trio or 3 exomes AND 3 more months network LMD subscription 
  • 240 Cases (6 cases per weekday average) Prize: 2 trios or 6 exomes AND 6 more months network LMD subscription
  • 360 Cases (9 cases per weekday average) Prize: 3 trios or 9 exomes AND 12 more months network LMD subscription


Terms: The top performing individuals and teams within each pledge category will be awarded the genetic testing vouchers that can be used for whole exome sequencing. Performance is based on total number of cases analyzed over 60 days, beginning when the user agrees to join the Face2Gene 60 Day Challenge. Testing vouchers will be for genetic testing at the sponsoring lab or a lab selected by FDNA. Recipients of the vouchers will select the case for which they want testing from the Face2Gene Unknown Forum. Genetic tests should be awarded to patients who would otherwise not have reasonably affordable access to such genetic tests and will be subject to the sponsor’s terms and conditions, as stipulated in the voucher. These cases can be their own cases or donated to other submitted cases within the forum. Questions can be directed to


Learn more about our partners at:


Blueprint Genetics:

MNG Laboratories:

Prevention Genetics:


Face2Gene User Community Includes Users From:

  • Using Face2Gene to reference all my department’s cases, share information with my colleagues and quickly look up relevant information in the London Medical Databases Online saves me hours of work every week and allows me to focus on my patients.

    Dr. Ibrahim Akalin

    Assoc. Prof. Ibrahim Akalin, MD, Medical Geneticist from the Istanbul Medeniyet University, Istanbul, Turkey

  • FDNA’s game-changing technology introduces an objective computer-aided dimension to the “art of dysmorphology”, transforming the analysis into an evidence-based science.

    Dr. Michael R. Hayden

    Chairman of FDNA’s Scientific Advisory Board & Steering Committee and Editor in Chief of Clinical Genetics

  • FDNA is developing technology that has the potential to help so many physicians and families by bringing them closer to a diagnosis- there are literally millions of individuals with unusual features around the world that lack a diagnosis and therefore lack information on natural history, recurrence risk and prevention of known complications.

    Dr. Judith G. Hall

    Professor Emerita of Pediatrics & Medical Genetics UBC & Children's and Women's Health Centre of BC

  • FDNA has been “right on the money”, providing me with relevant, accurate and insightful information for differential diagnoses.

    Dr. Cynthia J.R. Curry

    Professor of Pediatrics UCSF, Adjunct Professor of Pediatrics Stanford

  • I am excited to be a part of the FDNA community, promoting broad information sharing with my peers to amplify the scientific and clinical value of our community’s accumulated knowledge for the purpose of efficiently diagnosing individuals with rare genetic disorders.

    Dr. Karen W. Gripp

    Chief, Division of Medical Genetics A.I. duPont Hospital for Children

  • FDNA's idea of incorporating several dysmorphology resources (OMIM, GeneReviews), supported by their visual analytic technology, will be able to improve researching of genetic syndromes - all within a single mobile app.

    Dr. Chad Haldeman-Englert

    Assistant Professor Pediatrics at Mission Fullerton Genetics

  • Given the advancement of visual analytical technology, it’s about time Dysmorphology is supported with computational capabilities and moving this to mobile support, is simply the next logical step.

    Dr. Chanika Phornphutkul

    Associate Professor of Pediatrics Director, Division of Human Genetics Department of Pediatrics Warren Alpert Medical School of Brown University

  • Having an archive of cases easily accessible from my mobile device anytime and anywhere is a long-time unmet need.

    Dr. Lynne Bird

    Rady Children's Specialists of San Diego

  • FDNA's solution is a huge leap forward for dysmorphology. It saves me significant time when I’m evaluating patients in my clinic and provides me with insightful tools that help me generate a differential diagnosis.

    Dr. David A. Chitayat

    Head of the Prenatal Diagnosis and Medical Genetics Program at Mount Sinai Hospital, Toronto

  • Shortly after learning about Face2Gene, I’ve started to incorporate this amazing tool into my workflow. Soon enough, Face2Gene’s analysis flushed out references that I would not have considered for several of my patients, which turned out to be their correct diagnosis

    Dr. Zvi U. Borochowitz

    Chairman (Retired) of The Simon Winter Institute for Human Genetics at Bnai-Zion Medical Center, Technion-Rappaport Faculty of Medicine

  • The Unknown Forum from Face2Gene is a great community platform for exchanging opinions regarding undiagnosed cases. It is straightforward to use and safe for exchange of medical data, thanks to the efforts of its developers and to the involvement of geneticists worldwide.

    Dr. Oana Moldovan

    Clinical Geneticist at the Hospital Santa Maria, CHLN, Lisbon, Portugal